Former Ardent Health exec plans 35,930-share sale

Ardent Health, Inc. (ARDT) is the issuer for a Rule 144 notice covering planned sales of common stock held for the account of former officer and director Martin Bonick.

Rhea-AI Filing Summary

Ardent Health, Inc. (ARDT) is the issuer for a Rule 144 notice covering planned sales of common stock held for the account of former officer and director Martin Bonick. The filing lists up to 35,930 shares of common stock, with an aggregate market value of $377,363.99, proposed for sale on 08/20/2026 through Fidelity Brokerage Services LLC on the NYSE. It also notes that the shares to be sold include restricted stock vesting events of 8,994 shares on 03/31/2026 and 26,936 shares on 04/01/2026, received from the issuer as compensation, and discloses a prior sale of 35,930 shares on 08/18/2026 for $393,481.70.

Key Figures

Shares proposed to be sold: 35,930 shares Aggregate market value of proposed sale: $377,363.99 Shares sold in past 3 months: 35,930 shares +3 more

6 metrics

Shares proposed to be sold 35,930 shares Common stock proposed for sale on 08/20/2026 under Rule 144

Aggregate market value of proposed sale $377,363.99 Value of 35,930 shares of common stock covered by the notice

Shares sold in past 3 months 35,930 shares Common stock sold on 08/18/2026 by or for Martin Bonick

Proceeds from past 3 months sale $393,481.70 Total proceeds from 35,930 shares sold on 08/18/2026

Restricted stock vesting 03/31/2026 8,994 shares Restricted stock vesting from issuer as compensation

Restricted stock vesting 04/01/2026 26,936 shares Restricted stock vesting from issuer as compensation

Key Terms

Rule 144, Restricted Stock Vesting, Aggregate Market Value, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 03/31/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Aggregate Market Value financial

"35930 | 377363.99 | 141045907 | 08/20/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

attorney-in-fact regulatory

"as attorney-in-fact for Martin Bonick"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does this Form 144 filing mean for Ardent Health, Inc. (ARDT)?

The filing reports a planned sale under Rule 144 of Ardent Health, Inc. common stock held for former officer and director Martin Bonick. It is a disclosure of potential secondary market sales and does not describe any new issuance of shares by the company.

How many ARDT shares are covered by Martin Bonick’s planned Rule 144 sale?

The notice covers up to 35,930 shares of Ardent Health, Inc. common stock, with an aggregate market value of $377,363.99, proposed for sale on 08/20/2026 through Fidelity Brokerage Services LLC on the NYSE.

What prior ARDT stock sales by Martin Bonick are disclosed in this Form 144?

The filing discloses that on 08/18/2026, 35,930 shares of Ardent Health, Inc. common stock were sold for total proceeds of $393,481.70. This relates to the requirement to report securities sold during the past three months.

What is the source of the Ardent Health (ARDT) shares to be sold under this notice?

The shares come from restricted stock vesting granted by the issuer as compensation: 8,994 shares vesting on 03/31/2026 and 26,936 shares vesting on 04/01/2026, both listed as compensation from Ardent Health, Inc.

Who is executing the planned sale of ARDT shares for Martin Bonick?

The planned sale of up to 35,930 shares of Ardent Health, Inc. common stock is to be executed through Fidelity Brokerage Services LLC. The Form 144 is signed by Jared Cook as a duly authorized representative and attorney-in-fact for Martin Bonick.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/20/2026 - 04:24 PM EDT Accepted by SEC EDGAR 08/20/2026 - 04:23 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001598595
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Ardent Health, Inc.
SEC File Number	001-42180
Address of Issuer	340 SEVEN SPRINGS WAY SUITE 100 BRENTWOOD TENNESSEE 37027
Phone	6152963000
Name of Person for Whose Account the Securities are To Be Sold	Bonick Martin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Officer & Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	35930	377363.99	141045907	08/20/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/31/2026	Restricted Stock Vesting	Issuer			8994	03/31/2026	Compensation
Common	04/01/2026	Restricted Stock Vesting	Issuer			26936	04/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Martin Bonick 340 Seven Springs Way Suite 100 Brentwood TN 37027	Common	08/18/2026	35930	393481.70

144: Remarks and Signature

Remarks
Date of Notice	08/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jared Cook, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Martin Bonick
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)